Related Experiment Video
Updated: Jan 9, 2026

Author Spotlight: Enhancing Coronary Artery Revascularization
Published on: September 15, 2023
Current trends in hybrid coronary revascularization
Magdalena Synak1, Mateusz Hulbój2, Witold Gerber3,4
1Department of Cardiology, Andrzej Frycz Modrzewski Krakow University, Krakow, Poland.
Insights
Hybrid coronary revascularization (HCR) offers a less invasive approach for multivessel coronary artery disease, showing benefits over traditional methods. Further research is needed to confirm its long-term advantages and cost-effectiveness.
Area of Science:
- Cardiovascular Surgery
- Interventional Cardiology
Background:
- Hybrid coronary revascularization (HCR) combines surgical and percutaneous techniques for multivessel coronary artery disease (MVD).
- It integrates left internal mammary artery (LIMA) grafting to the left anterior descending artery (LAD) with percutaneous coronary intervention (PCI) for other lesions.
- HCR aims to reduce invasiveness while maintaining treatment effectiveness.
Purpose of the Study:
- To review and summarize current evidence on the safety, effectiveness, and clinical outcomes of HCR.
- To compare HCR with traditional coronary artery bypass grafting (CABG), PCI, and off-pump coronary artery bypass (OPCAB).
Main Methods:
- A comprehensive literature review was performed.
- Included studies encompassed clinical trials, meta-analyses, and observational studies.
- Analysis focused on procedural techniques, patient selection criteria, and patient outcomes.
Main Results:
- HCR demonstrated shorter hospital stays, reduced bleeding, and faster recovery compared to CABG.
- Compared to PCI, HCR showed improved LAD graft patency and fewer repeat interventions.
- HCR outcomes were comparable to OPCAB, with a noted reduction in myocardial injury.
Conclusions:
- HCR presents significant advantages in terms of recovery and effectiveness for MVD.
- Underutilization persists due to technical complexities and facility limitations.
- Further randomized controlled trials are essential to validate long-term safety, efficacy, and cost-effectiveness.
Introduction:
Hybrid coronary revascularization (HCR) is a combined approach for multivessel coronary artery disease (MVD), integrating surgical grafting of the left internal mammary artery (LIMA) to the left anterior descending artery (LAD) with percutaneous coronary intervention (PCI) for non-LAD lesions. It aims to reduce invasiveness while maintaining effectiveness.
Aim:
To summarize current evidence on the safety, effectiveness, and clinical outcomes of HCR compared to coronary artery bypass grafting (CABG), PCI, and off-pump coronary artery bypass (OPCAB).
Methods:
A review of current literature including clinical trials, meta-analyses, and observational studies was conducted. Focus was placed on procedural techniques, patient selection, and outcomes.
Results:
HCR is associated with shorter hospital stays, reduced bleeding, and faster recovery compared to CABG. Compared to PCI, it shows improved LAD patency and fewer repeat interventions. Outcomes are similar to OPCAB, with lower myocardial injury. Despite its benefits, HCR remains underused due to technical demands and limited availability of hybrid facilities.
Conclusions:
Further randomized trials are needed to confirm its long-term safety, effectiveness, and cost-efficiency.
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Coronary Artery Disease IV: Preventive Measures
Acute Coronary Syndrome III: Diagnostic Studies
Coronary Artery Disease I: Introduction
Coronary Circulation
Coronary circulation begins at the base of the aorta, where two main arteries arise—the left and right coronary arteries. These arteries encircle the heart in the coronary sulcus and supply the...
Cardiac Catheterization II: Right Heart Catheterization

